Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-07-12 Sale | 2023-07-14 4:00 pm | Taysha Gene Therapies Inc. | TSHA | Session R.A. II 10% Owner | 85,872 | $0.70769 | $60,771 | 9,153,927 (Indirect Direct) | View |
| 2023-06-22 Sale | 2023-06-26 4:46 pm | Taysha Gene Therapies Inc. | TSHA | Session R.A. II 10% Owner | 28,608 | $0.70327 | $20,119 | 9,239,799 (Indirect Direct) | View |
| 2023-06-20 Sale | 2023-06-22 4:00 pm | Taysha Gene Therapies Inc. | TSHA | Session R.A. II 10% Owner | 434,615 | $0.70831 | $307,844 | 9,268,407 (Indirect Direct) | View |
| 2021-11-23 Purchase | 2021-12-08 4:05 pm | Taysha Gene Therapies Inc. | TSHA | Session R.A. II President and CEO 10% Owner | 42,518 | $12.44 | $529,102 | 9,473,100 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-06 Disposition | 2023-03-08 7:38 pm | N/A 2032-11-10 | Taysha Gene Therapies Inc. | TSHA | Session R.A. II 10% Owner | 199,500 | $0 | 9,954,318 (Direct) | View |
| 2023-03-06 Other | 2023-03-08 7:38 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Session R.A. II 10% Owner | 251,296 | $0 | 9,954,318 (Direct) | View |
| 2022-11-10 Option Award | 2022-12-23 4:15 pm | N/A 2032-11-10 | Taysha Gene Therapies Inc. | TSHA | Session R.A. II Director 10% Owner | 199,500 | $0 | 199,500 (Direct) | View |
| 2022-02-23 Option Award | 2022-02-25 4:17 pm | N/A 2032-02-23 | Taysha Gene Therapies Inc. | TSHA | Session R.A. II President and CEO 10% Owner | 217,850 | $0 | 217,850 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-20 8:22 pm | N/A 2031-01-19 | Taysha Gene Therapies Inc. | TSHA | Session R.A. II President and CEO 10% Owner | 199,700 | $0 | 199,700 (Direct) | View |
Ownership | 2020-09-23 8:32 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Session R.A. II President and CEO 10% Owner | 0 | $0 | 9,430,582 (Direct) | View |
Ownership | 2020-04-27 1:42 pm | N/A N/A | Chardan Healthcare Acquisition 2 Corp. | CHAQ | Session R.A. II Director | 0 | $0 | 10,000 (Direct) | View |